BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 17166607)

  • 1. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale.
    Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
    Int J Cardiol; 2007 Sep; 120(3):357-62. PubMed ID: 17166607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting.
    Giardini A; Donti A; Formigari R; Salomone L; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am Heart J; 2006 Apr; 151(4):922.e1-5. PubMed ID: 16569564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
    Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke.
    Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):625-9. PubMed ID: 16548006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine headache relief after transcatheter closure of patent foramen ovale.
    Reisman M; Christofferson RD; Jesurum J; Olsen JV; Spencer MP; Krabill KA; Diehl L; Aurora S; Gray WA
    J Am Coll Cardiol; 2005 Feb; 45(4):493-5. PubMed ID: 15708692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombophilia and patent foramen ovale in young stroke patients].
    Carod-Artal FJ; Vilela Nunes S; Portugal D
    Neurologia; 2006 Dec; 21(10):710-6. PubMed ID: 17106824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study.
    Cerrato P; Priano L; Imperiale D; Bosco G; Destefanis E; Villar AM; Ribezzo M; Trevi GP; Bergamasco B; Orzan F
    Neurol Sci; 2006 Feb; 26(6):411-8. PubMed ID: 16601933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interatrial shunts and migraine headaches: impact of transcatheter closure.
    Azarbal B; Tobis J; Suh W; Chan V; Dao C; Gaster R
    J Am Coll Cardiol; 2005 Feb; 45(4):489-92. PubMed ID: 15708691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of atrial shunts to migraine in patients with ischemic stroke and peripheral emboli.
    Wilmshurst P; Nightingale S; Pearson M; Morrison L; Walsh K
    Am J Cardiol; 2006 Sep; 98(6):831-3. PubMed ID: 16950197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
    Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
    Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
    Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.